News

Two drugs that continuously contribute to Amgen Inc. (NASDAQ:AMGN)’s strong growth are EVENITY, which treats osteoporosis in postmenopausal women, and Repatha, which treats heart disease and ...
Older drugs such as Repatha for high cholesterol and Evenity, used to treat the bone disease osteoporosis in post-menopausal women, are still among Amgen's best performers. Lastly, the company has ...
Two drugs that continuously contribute to Amgen Inc. (NASDAQ:AMGN)’s strong growth are EVENITY, which treats osteoporosis in postmenopausal women, and Repatha, which treats heart disease and ...
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael Higgins. The plan seeks to maximize the yield of investments by buying the 10 highest-paying dividend stocks ...
Those lower results stem in part from discontinuation: 20% of patients stop taking drugs such as Leqvio (inclisiran) within a year, and 50% drop monoclonal antibodies such as Repatha (evolocumab) or ...
Papua New Guinea Prime Minister James Marape has survived a motion of no confidence against him in parliament. During the proceedings, livestreamed on EMTV, Speaker Job Pomat announced the results of ...
Papua New Guinea's parliament is set to sit today to debate a no-confidence vote against Prime Minister James Marape. The PNG Supreme Court ordered the House to resume last week to consider the motion ...
Papua New Guinea’s SP PNG Hunters celebrated a standout performance from Brandon Nima, who marked his 100th game in style, earning the title of this week's Peak Huntsman. Nima delivered an inspiring ...
PNG Govt is starting to look seriously at digital technology like Artificial Intelligence (AI) and cryptocurrency. This is part of a bigger plan to make government services better, faster and safer ...
Papua New Guinea Prime Minister James Marape has successfully retained his position after overcoming a vote of no confidence in a highly charged parliamentary sitting held on Monday. The session drew ...
Other companies are targeting PCSK9 to lower LDL-C. Amgen’s Repatha, and Sanofi and Regeneron’s Praluent, which are antibodies that inhibit PCSK9, were first to market. Later, Novartis won ...